Legal & General Group’s Prime Medicine PRME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.1K | Sell |
4,899
-1,016
| -17% | -$2.51K | ﹤0.01% | 3216 |
|
|
2025
Q1 | $11.8K | Sell |
5,915
-364
| -6% | -$724 | ﹤0.01% | 3120 |
|
|
2024
Q4 | $18.4K | Hold |
6,279
| – | – | ﹤0.01% | 3051 |
|
|
2024
Q3 | $24.3K | Hold |
6,279
| – | – | ﹤0.01% | 2972 |
|
|
2024
Q2 | $32.3K | Buy |
6,279
+1,943
| +45% | +$9.99K | ﹤0.01% | 2865 |
|
|
2024
Q1 | $30.3K | Hold |
4,336
| – | – | ﹤0.01% | 2854 |
|
|
2023
Q4 | $38.4K | Sell |
4,336
-188
| -4% | -$1.67K | ﹤0.01% | 2844 |
|
|
2023
Q3 | $43.1K | Sell |
4,524
-267
| -6% | -$2.54K | ﹤0.01% | 2884 |
|
|
2023
Q2 | $70.2K | Buy |
4,791
+1,364
| +40% | +$20K | ﹤0.01% | 2847 |
|
|
2023
Q1 | $42.2K | Buy |
3,427
+2,502
| +270% | +$30.8K | ﹤0.01% | 2903 |
|
|
2022
Q4 | $17.1K | Buy |
+925
| New | +$17.1K | ﹤0.01% | 3188 |
|